Provided by Tiger Trade Technology Pte. Ltd.

Regeneron Pharmaceuticals

739.57
-2.5500-0.34%
Post-market: 739.570.00000.00%19:30 EDT
Volume:500.29K
Turnover:367.35M
Market Cap:76.14B
PE:18.29
High:744.50
Open:742.12
Low:723.65
Close:742.12
52wk High:859.34
52wk Low:541.00
Shares:102.95M
Float Shares:98.88M
Volume Ratio:0.70
T/O Rate:0.51%
Dividend:3.64
Dividend Rate:0.49%
EPS(TTM):40.43
EPS(LYR):41.48
ROE:14.04%
ROA:6.53%
PB:2.40
PE(LYR):17.83

Loading ...

Movement Alert|Regeneron Pharmaceuticals Rises 3.01% in Regular Trading, Multiple Catalysts Boost Sentiment

Market Focus
·
Aug 11

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 08

Sanofi, Regeneron Seem Keen to Keep Working Together

Dow Jones
·
Aug 07

Regeneron Posts Transcript of Q2 2026 Earnings Conference Call

Reuters
·
Aug 07

Regeneron Canada Says Libtayo Receives Health Canada Approval for Treatment of a Type of Carcinoma

Reuters
·
Aug 06

Regeneron announces Health Canada approval of new indication for Libtayo

TIPRANKS
·
Aug 06

Regeneron Canada: Libtayo Receives Health Canada Approval for Adjuvant Treatment of High-Risk Cutaneous Squamous Cell Carcinoma

THOMSON REUTERS
·
Aug 06

Intellia Therapeutics Q2 Collaboration Revenue Falls, Net Loss Widens

Reuters
·
Aug 06

Intellia Q2 FY26 Net Loss Widens to $106.63 Million; Revenue Falls to $7.66 Million

Reuters
·
Aug 06

Regeneron Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Aug 06

Wall Street Warms to Healthcare Stocks as Tech Trade Faces Turbulence

Reuters
·
Aug 05

Does Regeneron (REGN) Prioritize Shareholder Returns Over Earnings Quality As Profit Slips Amid Rising Sales?

Simply Wall St.
·
Aug 04

Fujian Haixi Pharma Wins FDA IND Clearance for Hx9428 Phase II nAMD Trial

Reuters
·
Aug 04

Regeneron Pharma is Maintained at Buy by Guggenheim

Dow Jones
·
Aug 03

Achieve Life Sciences Names Ronald Dadino SVP of CMC and Supply Chain

Reuters
·
Aug 03

Regeneron Pharmaceuticals (REGN) Posts Strong Q2 Revenue, Is The Upside Already Priced In?

Simply Wall St.
·
Aug 03

Regeneron price target raised to $740 from $700 at Citi

TIPRANKS
·
Aug 03

Biocon Launches Yesafili Biosimilar to Regeneron’s Eylea in US

Reuters
·
Aug 03

Weekly Winners | Microsoft Rockets 22%; Garmin Soars 21%; Amazon, Chipotle Jump 17% Each; Regeneron Pharmaceuticals Gains 16%

Tiger Newspress
·
Aug 02

Movement Alert|Regeneron Pharmaceuticals Rises 3.09% in Regular Trading, Q2 Earnings Beat Continues to Drive Stock Higher

Market Focus
·
Aug 01